M. David MacFarlane, Director at TITAN PHARMACEUTICALS INC (TTNP.OB), bought 80,000 shares at $0.25 ($20K) on 2018-09-21, disclosed to the SEC on 2018-09-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.